Article and Video CATEGORIES

Cancer Journey

Search By

Lung Cancer Video Library - Can Serum Tumor Markers Be Used in the Management of Lung Cancer?
Wed, 01/27/2016 - 06:00
Author
GRACE Videos and Articles
Image
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC describes the use of serum tumor markers in various types of cancer, and the lack of a useful serum tumor marker in lung cancer.

 

Download Transcript

 

Transcript

Now, we’ve talked about ways of doing what we call liquid biopsies, and trying to measure tumors in the blood, but we don’t have any system with those technologies, as of yet — this will be summer of 2015, that we can actually use them to track or measure cancer and its response to therapy.

There are some other cancers out there, such as those that involve the bowel, or the colon, or the esophagus, in which, after you’ve already diagnosed a cancer, you can use a blood marker. One is called CEA, or carcinoembryonic antigen. This CEA is something that will rise when there is more cancer, or fall when there is less cancer. So, if one is being treated with chemotherapy, a physician can follow this level during the course of therapy, and after therapy, they can follow the levels and see if they begin to rise.

CA 125 in ovarian cancer is another example of where you have a blood marker that will actually rise or fall in the response for therapy. You can also use CA 125 to detect if there is cancer, and you can also use something we call PSA, or prostate specific antigen, to diagnose and follow prostate cancer. It’s an important distinction on these blood markers — some we can use to actually help diagnose: PSA, CA 125, and some we can’t use to diagnose as accurately, but we can use them to see the effect of treatment, after you’ve been diagnosed and started on therapy, something like CEA.

Unfortunately, in lung cancer, we don’t have anything right now that helps us follow the course and response of a lung cancer during treatment. Really, we rely on two things. One is serial radiographic assessment, with CAT scans, PET scans, wherever the site of disease is, and two, how the patient, themselves, is feeling. So, that’s a clinical response that we look for — we also, then, look for a radiographic response, and if both the patient is feeling better, and the tumor is shrinking, that is the best case scenario.

But right now, there isn’t anything we have, as far as a blood marker, that we use to follow serially.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Community Forum

Hi Carole, Welcome to Grace. If the adrenal is the only place that cancer has been seen since your lobectomy it could be that it's what's known as a precocious metastasis/oligoprogression...

Carole,

These approaches haven't been directly compared, and it really depends on who can do the job and what they say is appropriate to expect in terms of side effects. In...

Hi CDaniele,
Welcome to Grace. If the TKI is working except for one or 2 places local treatment such as radiation can be used to get rid of the resistant cells...

I forgot to tell you that Grace is having its annual OncTalk live forum online Saturday, Dec. 11 at 8 am Pacific and 11 am Eastern
It will be invaluable to...

This is indeed a happy Thanksgiving in our house. I'll post about it at soon but we've just come out of a dark place and are feeling so hopeful today.
As...

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that we are here! You are a very important part of the GRACE...

Hi and welcome to Grace.  I'm sorry your sister-in-law is going through this it's so unsettling, to say the least.  Cancer travels through the lymph system but also through blood vessels. ...

Recent Comments

JOIN THE CONVERSATION
Carole,These approaches…
By Dr West on Thu, 12/02/2021 - 20:49
Happy!
By dbrock on Thu, 12/02/2021 - 15:32
Hi Carole, Welcome to Grace…
By Dr West on Thu, 12/02/2021 - 13:22
Bump
By JanineT Forum … on Wed, 12/01/2021 - 10:24